Patent Application
20240060080
A sequence listing contained in the file named “CSUV002USC1_ST26.xml” which is 87 kilobytes (measured in MS-Windows®) and created on May 18, 2023, is filed electronically herewith and incorporated by reference in its entirety.
The present disclosure relates to the field of biotechnology. More specifically, the disclosure relates to compositions and methods for generation of plants that can remove a salt or other impurity from water, for example plants that can remove sodium chloride from salt or sea water. As such, the present disclosure also provides methods for engineering crop plants, for example rice, for growth in saline water.
One of the greatest limits to humanity and sustainable life on Earth is fresh water. However, the majority of water on Earth is salt water. Physical structures assembled as commercial desalination systems, i.e., conventional desalination plants, are able to produce fresh water from salt water, but these structures are extremely expensive to build and maintain, use the energy equivalent of a city of 50,000 people, and generate massive amounts of salt brine that must be re-pumped out into the ocean. Therefore, the fresh water that is produced is very expensive, and not done in a sustainable manner.
What is needed are new compositions and methods for generation of fresh water from salt water, grey water, or otherwise contaminated water, for a relatively low cost and in a sustainable manner.
The present disclosure provides a transgenic plant genetically engineered to produce purified water, comprising genetically encoded physical barrier components, genetically encoded water filtering and transport components, and genetically encoded water retention and pumping components, wherein the plant produces purified water when grown in water containing an impurity, and wherein at least one of the components is exogenously provided to the plant.
In certain embodiments the genetically encoded physical barrier components comprise suberin and a Casparian Strip. In particular embodiments the suberin is encoded by a MYB41 gene that has been mutated to encode an aspartate residue at amino acid 251, for example SEQ ID NO:13. In various embodiments, the MYB41 gene is from a dicot plant, such as, but not limited to, Arabidopsis thaliana, Eutrema salsugineum, or Brassica napus. Examples of such MYB41 genes are provided herein as SEQ ID NO:14 and SEQ ID NO:15. In other embodiments, the MYB41 gene is from a monocot plant, such as, but not limited to, a rice plant. Examples of such MYB41 genes are provided herein as SEQ ID NO:41, SEQ ID NO:42 and SEQ ID NO:43. In some embodiments the Casparian Strip is encoded by a MYB36 gene. In certain embodiments the MYB36 gene is from a dicot plant, such as, but not limited to, Arabidopsis thaliana, Eutrema salsugineum, or Brassica napus. Examples of such MYB36 genes are provided herein as SEQ ID NO:10, SEQ ID NO:11 and SEQ ID NO:12. In further embodiments the MYB36 gene is from a monocot plant, such as, but not limited to, a rice plant. Examples of such MYB36 genes are provided herein as SEQ ID NO:44, SEQ ID NO:45 and SEQ ID NO:46.
In certain embodiments the genetically encoded water filtering and transport components comprise an aquaporin. In some embodiments the aquaporin has been codon optimized for expression in the plant. In various embodiments the aquaporin is a plasma membrane intrinsic protein (PIP) or a tonoplast intrinsic membrane protein (TIP). In some embodiments the genetically encoded water filtering components comprise a plurality of distinct aquaporins. In further embodiments the genetically encoded water filtering components comprise a PIP and a TIP. In particular embodiments the PIP is from a dicot plant, such as, but not limited to, Avicennia officinalis, Aegiceras corniculatum or Bruguiera gymnorrhiza. Examples of such PIPs are provided herein as SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4 and SEQ ID NO:5. In certain embodiments the plasma membrane intrinsic protein is encoded by the is AoPIP1.2 gene from Avicennia officinalis (SEQ ID NO:1) or BgPIP2 from Bruguiera gymnorrhiza (SEQ ID NO:3). In further embodiments the PIP is from a monocot plant, such as, but not limited to, a rice plant. Rice has 11 known PIPs, which are contemplated for use in various embodiments of the present disclosure. In some embodiments the TIP gene is from a dicot plant, such as, but not limited to, Bruguiera gymnorrhiza, Kandelia candel, and Eutrema salsugineum. Examples of such TIPs are provided herein as SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8 and SEQ ID NO:9. In other embodiments the TIP gene is TsTIP1.2 from Eutrema salsugineum (SEQ ID NO:6). In further embodiments the TIP is from a monocot plant, such as, but not limited to, a rice plant. Rice has 10 known TIPs, which are contemplated for use in various embodiments of the present disclosure.
In certain embodiments the genetically encoded physical barrier components and the genetically encoded water filtering and transport components are expressed by a root epidermal promoter. In some embodiments the root epidermal promoter is from a dicot plant, such as, but not limited to, Arabidopsis thaliana. Examples of such promoters are provided herein as SEQ ID NO:27 and SEQ ID NO:28. In further embodiments the root epidermal promoter is an ABC transporter promoter, a CLAVATA3/ESR-related 14 (CLE14) promoter, or an iron regulated transporter (IRT2) promoter from Arabidopsis thaliana. In other embodiments the root epidermal promoter is from a monocot plant, such as, but not limited to, a rice plant. Examples of such rice root epidermal promoters are provided herein as Os02g51110 (SEQ ID NO:34) and Os03g01700 (SEQ ID NO:35) promoters. In additional embodiments the root epidermal promoter is a synthetic promoter, including, but not limited to, synthetic promoter pSynEpiProm 1.0 4-block (SEQ ID NO:32) and synthetic promoter pSynEpiProm 1.0 7-block (SEQ ID NO:33).
In certain embodiments the genetically encoded water retention and pumping components comprise a mannitol biosynthesis protein and a mannitol transport protein. Examples of mannitol biosynthesis protein genes are provided herein as SEQ ID NO:20, SEQ ID NO:21, SEQ ID NO:24, SEQ ID NO:25 and SEQ ID NO:26. Examples of mannitol transport protein genes are provided herein as SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:22 and SEQ ID NO:23. In further embodiments the mannitol biosynthesis protein gene and/or the mannitol transport protein gene is from a dicot plant, such as, but not limited to, Arabidopsis thaliana, Daucus carota, Brassica napus, Olea europaea, Methanohalophilus portucalensis or Apium graveolens. In some embodiments the mannitol biosynthesis protein is encoded by a mannose-6-phosphate reductase gene. In particular embodiments the mannose-6-phosphate reductase gene from Apium graveolens has been codon optimized for expression in the plant, for example the sequence provided herein as SEQ ID NO:19. In other embodiments the mannitol transport protein is encoded by a mannitol transporter gene. In certain embodiments the mannitol transporter gene from Apium graveolens has been codon optimized for expression in the plant, for example the sequence provided herein as SEQ ID NO:16. In some embodiments the genetically encoded water retention and pumping components are expressed by a parenchyma-specific promoter. In particular embodiments the parenchyma-specific promoter is from a dicot plant, such as, but not limited to, Arabidopsis thaliana. In further embodiments the parenchyma-specific promoter is an XCP1 promoter (SEQ ID NO:31), a VND7 promoter (SEQ ID NO:30) or a CESA7 promoter (SEQ ID NO:29) from Arabidopsis thaliana.
In certain embodiments of the present disclosure the plant is a monocot plant, such as, but not limited to, a rice, wheat, barley, oats, rye, sorghum or maize plant. In other embodiments of the present disclosure the plant is a dicot plant, such as, but not limited to, a soybean, alfalfa, sunflower, cotton, canola, sugar beet, sweet potato, tomato, strawberry, tobacco, banana, grape, cucurbits, pepper, beach plum, wax myrtle, mesquite, salt cedar, crossvine, withe vine, acacia, or laurel fig plant. In further embodiments the plant is able to grow in salt or sea water. In various embodiments the plant produces purified water when grown in salt or sea water.
The present disclosure also provides a plant part from a transgenic plant genetically engineered to produce purified water, comprising genetically encoded physical barrier components, genetically encoded water filtering and transport components, and genetically encoded water retention and pumping components, wherein the plant produces purified water when grown in water containing an impurity, and wherein at least one of the components is exogenously provided to the plant. In various embodiments the plant part is a cell, meristem, root, leaf, node, pistil, anther, flower, seed, embryo, stalk or petiole.
The present disclosure further provides a method of producing purified water from salt or sea water, comprising growing a transgenic plant genetically engineered to produce purified water, comprising genetically encoded physical barrier components, genetically encoded water filtering and transport components, and genetically encoded water retention and pumping components, wherein the plant produces purified water when grown in water containing an impurity, and wherein at least one of the components is exogenously provided to the plant, in salt of sea water and collecting the purified water produced by the plant.
The present disclosure additionally provides a nucleic acid construct, comprising genetically encoded physical barrier components, genetically encoded water filtering and transport components, and genetically encoded water retention and pumping components. In certain embodiments components a) through c) are separately comprised in a plurality of nucleic acid vectors. In other embodiments components a) through c) are comprised in a single vector. In various embodiments any of components a) through c) are operably linked to a termination sequence. In other embodiments all of components a) through c) are operably linked to a termination sequence. In some embodiments any of components a) through c) are operably linked to a transcriptional enhancer sequence. In further embodiments all of components a) through c) are operably linked to a transcriptional enhancer sequence.
SEQ ID NO:1: Aquaporin AoPIP1.2 from Avicennia officinalis, Arabidopsis codon optimized.
SEQ ID NO:2: Aquaporin AcPIP1 ortholog from Aegiceras corniculatum, Arabidopsis codon optimized.
SEQ ID NO:3: Aquaporin BgPIP2 from Bruguiera gymnorrhiza, Arabidopsis codon optimized.
SEQ ID NO:4: Aquaporin AcPIP2 ortholog from Aegiceras corniculatum, Arabidopsis codon optimized.
SEQ ID NO:5: Aquaporin AoPIP2 ortholog from Avicennia officinalis, Arabidopsis codon optimized.
SEQ ID NO:6: Aquaporin TsTIP1.2 from Eutrema salsugineum, Arabidopsis codon optimized.
SEQ ID NO:7: Aquaporin BgTIP ortholog from Bruguiera gymnorrhiza, Arabidopsis codon optimized.
SEQ ID NO:8: Aquaporin KcTIP ortholog from Kandelia candel, Arabidopsis codon optimized.
SEQ ID NO:9: Aquaporin TsTIP1.1 ortholog from Eutrema salsugineum, Arabidopsis codon optimized.
SEQ ID NO:10: Transcription factor AtMYB36 from Arabidopsis thaliana, for controlling production of water barrier.
SEQ ID NO:11: Transcription factor MYB36 ortholog from Eutrema salsugineum, for controlling production of water barrier.
SEQ ID NO:12: Transcription factor MYB36 ortholog from Brassica napus, for controlling production of water barrier.
SEQ ID NO:13: Transcription factor AtMYB41 S251D mutant from Arabidopsis thaliana, for controlling production of water barrier.
SEQ ID NO:14: Transcription factor MYB41-like ortholog from Brassica napus, for controlling production of water barrier.
SEQ ID NO:15: Transcription factor MYB41 ortholog from Eutrema salsugineum, for controlling production of water barrier.
SEQ ID NO:16: Mannitol transporter MaT2 (MTR) from Apium graveolens, Arabidopsis codon optimized.
SEQ ID NO:17: Mannitol transporter 1 ortholog from Olea europaea.
SEQ ID NO:18: Polyol transporter 5-like ortholog from Daucus carota.
SEQ ID NO:19: Mannose-6-phosphate reductase (M6PR) from Apium graveolens, Arabidopsis codon optimized.
SEQ ID NO:20: Putative NADPH dependent mannose 6-phosphate reductase ortholog from Arabidopsis thaliana.
SEQ ID NO:21: NADP-dependent D-sorbitol-6-phosphate dehydrogenase like ortholog from Daucus carota.
SEQ ID NO:22: AtPRO2 transporter (glycine betaine and proline transporter) from Arabidopsis thaliana.
SEQ ID NO:23: Proline transporter 2 ortholog from Brassica napus.
SEQ ID NO:24: Glycine Sarcosine N-methyltransferase (AtGSMT) from Methanohalophilus portucalensis, Arabidopsis codon optimized.
SEQ ID NO:25: Sarcosine Dimethylglycine N-Methyltransferase (AtSDMT) from Methanohalophilus portucalensis, Arabidopsis codon optimized.
SEQ ID NO:26: Delta 1-pyrroline-5-carboxylate synthase 1 (P5CS1) from Arabidopsis thaliana.
SEQ ID NO:27: pABC transporter promoter from Arabidopsis thaliana.
SEQ ID NO:28: pKC1 promoter from Arabidopsis thaliana.
SEQ ID NO:29: pCESA7 promoter from Arabidopsis thaliana.
SEQ ID NO:30: pVND7 promoter from Arabidopsis thaliana.
SEQ ID NO:31: pXCP1 promoter from Arabidopsis thaliana.
SEQ ID NO:32: Synthetic promoter pSynEpiProm 1.0 4-block.
SEQ ID NO:33: Synthetic promoter pSynEpiProm 1.0 7-block.
SEQ ID NO:34: Os02g51110 promoter from Oryza sativa.
SEQ ID NO:35: Os03g01700 promoter from Oryza sativa.
SEQ ID NO:36: 5′-UTR sequence AoPiP1.2 from Oryza sativa.
SEQ ID NO:37: 5′-UTR sequence Myb41 from Oryza sativa.
SEQ ID NO:38: 5′-UTR sequence BgPIP2 from Oryza sativa.
SEQ ID NO:39: 5′UTR sequence TsTIP1.2 from Oryza sativa.
SEQ ID NO:40: 5′UTR sequence Omega-Myb36 from Oryza sativa.
SEQ ID NO:41: Os07g37210.1 MYB41 homolog from Oryza sativa.
SEQ ID NO:42: Os04g50770.1 MYB41 homolog from Oryza sativa.
SEQ ID NO:43: Os02g46780.1 MYB41 homolog from Oryza sativa.
SEQ ID NO:44: Os08g15020.1 MYB36 homolog from Oryza sativa.
SEQ ID NO:45: Os01g49160.1 MYB36 homolog from Oryza sativa.
SEQ ID NO:46: Os01g09590.1 MYB36 homolog from Oryza sativa.
The present disclosure describes compositions and methods for removing salts and other impurities from water, for example removing NaCl from sea or salt water, and in filtering the entry of water into plants, provides a method to grow any and all types of crops, for example rice, under saline conditions.
Fresh water is an absolutely vital necessity for life on Earth. However, certain plants can actually live in salt water. Mangroves are land plants that live in salt water, tidal zones, hypersaline environments, and wetlands, and naturally desalinate seawater (Scholander, Physiol. Plantarum 21:251, 1968). Mangroves, as all land plants, must use pure water for life. However, mangroves retain the water that they desalinate (e.g., the vegetative portions of mangroves resemble desert plants).
The present disclosure provides a synthetic desalination gene circuit based, in part, on the natural processes used by mangroves that allow them to live in salt water. This gene circuit can be introduced into any plant species from model organisms in the laboratory to crop species to trees. Plants with this genetic circuit are able to filter 600 mM salt water (NaCl content greater than seawater, which is approximately 550 mM NaCl), and secrete pure water with ionic composition comparable to that of bottled water. As such, the presently described photosynthetically powered desalination system provides a pathway towards clean water for humanity and sustainable life on Earth. The design of the presently disclosed synthetic desalination circuit is based, in part, on how mangroves naturally desalinate sea water. This desalination ability is found in approximately 70 species of plants in 20 families. Therefore, the present desalination gene circuit takes advantage of the realization by the inventors that the desalination ability of mangroves likely involves adaptation and modification of natural plant features rather than independently evolving new desalination traits multiple times.
As used herein, the term “nucleic acid” or “polynucleotide” refers to a single or double-stranded polymer of deoxyribonucleotide bases or ribonucleotide bases read from the 5′ to the 3′ end. A nucleic acid or polynucleotide may also optionally contain non-naturally occurring or altered nucleotide bases that permit correct read through by a polymerase and do not reduce expression of a polypeptide encoded by that nucleic acid. The terms “nucleotide sequence” or “nucleic acid sequence” refer to both the sense and antisense strands of a nucleic acid as either individual single strands or in the duplex. The term “ribonucleic acid” (RNA) is inclusive of RNAi (inhibitory RNA), dsRNA (double stranded RNA), siRNA (small interfering RNA), mRNA (messenger RNA), miRNA (micro-RNA), tRNA (transfer RNA, whether charged or discharged with a corresponding acylated amino acid), and cRNA (complementary RNA). The words “nucleic acid fragment,” “nucleotide sequence fragment”, or more generally “fragment” will be understood by those in the art as a functional term that includes genomic sequences, ribosomal RNA sequences, transfer RNA sequences, messenger RNA sequences, operon sequences, and smaller engineered nucleotide sequences that express or may be adapted to express, proteins, polypeptides or peptides. The nomenclature used herein is that required by Title 37 of the United States Code of Federal Regulations § 1.822 and set forth in the tables in WIPO Standard ST.25 (1998), Appendix 2, Tables 1 and 3.
As used herein, the terms “nucleic acid” and “polynucleotide” thus refer to a deoxyribonucleotide, ribonucleotide, or a mixed deoxyribonucleotide and ribonucleotide polymer in either single- or double-stranded form, and unless otherwise limited, would encompass known analogs of natural nucleotides that can function in a similar manner as naturally-occurring nucleotides. The polynucleotide sequences include the DNA strand sequence that is transcribed into RNA and the strand sequence that is complementary to the DNA strand that is transcribed. The polynucleotide sequences also include both full-length sequences as well as shorter sequences derived from the full-length sequences. Allelic variations of the exemplified sequences also fall within the scope of the present disclosure. The polynucleotide sequence includes both the sense and antisense strands either as individual strands or in the duplex.
As used herein, the term “recombinant nucleic acid,” “recombinant polynucleotide” or “recombinant DNA molecule” refers to a polynucleotide that has been altered from its native state, such as by linkage to one or more other polynucleotide sequences to which the recombinant polynucleotide molecule is not normally linked to in nature. Such molecules may or may not be present, for example, in a host genome or chromosome.
The present disclosure further provides polynucleotides that are complementary in sequence to the polynucleotides disclosed herein. Polynucleotides and polypeptides of the disclosure can be provided in purified or isolated form.
The subject disclosure also concerns oligonucleotide probes and primers, such as polymerase chain reaction (PCR) primers, that can hybridize to a coding or non-coding sequence of a polynucleotide of the present disclosure. Oligonucleotide probes of the disclosure can be used in methods for detecting and quantitating nucleic acid sequences encoding the polypeptides of the disclosure. Oligonucleotide primers of the disclosure can be used in PCR methods and other methods involving nucleic acid amplification. In a preferred embodiment, a probe or primer of the disclosure can hybridize to a polynucleotide of the disclosure under stringent conditions. Probes and primers of the disclosure can optionally comprise a detectable label or reporter molecule, such as fluorescent molecules, enzymes, radioactive moiety (e.g., 3H, 35S, 125I, etc.), and the like. Probes and primers of the disclosure can be of any suitable length for the method or assay in which they are being employed. Typically, probes and primers of the disclosure will be 10 to 500 or more nucleotides in length. Probes and primers that are 10 to 20, 21 to 30, 31 to 40, 41 to 50, 51 to 60, 61 to 70, 71 to 80, 81 to 90, 91 to 100 or more nucleotides in length are contemplated within the scope of the disclosure. Probes and primers of the disclosure can have complete (100%) nucleotide sequence identity with the polynucleotide sequence, or the sequence identity can be less than 100%. For example, sequence identity between a probe or primer and a sequence can be 99%, 98%, 97%, 96%, 95%, 90%, 85%, 80%, 75%, 70% or any other percentage sequence identity allowing the probe or primer to hybridize under stringent conditions to a nucleotide sequence of a polynucleotide of the disclosure. In one embodiment, a probe or primer of the disclosure has 70% or greater, 75% or greater, 80% or greater, 85% or greater, 90% or greater, or 95% to 100% sequence identity with a nucleotide sequence provided herein, including the complement thereof.
Because of the degeneracy of the genetic code, a variety of different polynucleotide sequences can encode polypeptides or mutant polypeptides disclosed herein. All possible triplet codons (and where U also replaces T) and the amino acid encoded by each codon is well-known in the art. In addition, it is well within the capability of one of skill in the art to create alternative polynucleotide sequences encoding the same, or essentially the same, mutant polypeptides of the subject disclosure. These variant or alternative polynucleotide sequences are within the scope of the subject disclosure. As used herein, references to “essentially the same” sequence refers to sequences that encode amino acid substitutions, deletions, additions, or insertions that do not materially alter the functional activity of the polypeptide encoded by the polynucleotides of the present disclosure. Allelic variants of the nucleotide sequences encoding a wild-type or mutant polypeptide of the present disclosure are also encompassed within the scope of the disclosure.
Amino acids can be generally categorized in the following classes: non-polar, uncharged polar, basic, and acidic. Conservative substitutions whereby a polypeptide of the present disclosure having an amino acid of one class is replaced with another amino acid of the same class fall within the scope of the subject disclosure so long as the polypeptide having the substitution still retains substantially the same functional activity as the polypeptide that does not have the substitution. Functional activity may be determined as set forth in the Examples section below. Polynucleotides encoding a polypeptide having one or more amino acid substitutions in the sequence are contemplated within the scope of the present disclosure.
Table 1 provides a listing of examples of amino acids belonging to each class.
Glycine and cysteine are understood in the art to fall in both the nonpolar and uncharged polar classes. Substitution of amino acids other than those specifically exemplified or naturally present in the disclosed polypeptides are also contemplated within the scope of the present disclosure. For example, non-natural amino acids can be substituted for the amino acids of a polypeptide, so long as the polypeptide having the substituted amino acids retains substantially the same functional activity as the polypeptide in which amino acids have not been substituted. Examples of non-natural amino acids include, but are not limited to, ornithine, citrulline, hydroxyproline, homoserine, phenylglycine, taurine, iodotyrosine, 2,4-diaminobutyric acid, α-amino isobutyric acid, 4-aminobutyric acid, 2-amino butyric acid, γ-amino butyric acid, e-amino hexanoic acid, 6-amino hexanoic acid, 2-amino isobutyric acid, 3-amino propionic acid, norleucine, norvaline, sarcosine, homocitrulline, cysteic acid, t-butylglycine, t-butylalanine, phenylglycine, cyclohexylalanine, β-alanine, fluoro-amino acids, designer amino acids such as β-methyl amino acids, C-methyl amino acids, N-methyl amino acids, and amino acid analogues in general. Non-natural amino acids also include amino acids having derivatized side groups. Furthermore, any of the amino acids in the disclosed proteins or polypeptides can be of the D (dextrorotary) form or L (levorotary) form. Allelic variants of the disclosed polypeptides are also encompassed within the scope of the disclosure.
As used herein, “wild-type” means naturally occurring. A “wild-type DNA molecule,” “wild-type protein” is a naturally occurring version of a DNA molecule or protein, that is, a version of a DNA molecule or protein pre-existing in nature. A wild-type version of a DNA molecule or protein may be useful for comparison with a recombinant or engineered DNA molecule or protein.
The subject disclosure also concerns variants of the polynucleotides of the present disclosure that encode functional polypeptides of the disclosure. Variant sequences include those sequences wherein one or more nucleotides of the sequence have been substituted, deleted, and/or inserted. The nucleotides that can be substituted for natural nucleotides of DNA have a base moiety that can include, but is not limited to, inosine, 5-fluorouracil, 5-bromouracil, hypoxanthine, 1-methylguanine, 5-methylcytosine, and tritylated bases. The sugar moiety of the nucleotide in a sequence can also be modified and includes, but is not limited to, arabinose, xylulose, and hexose. In addition, the adenine, cytosine, guanine, thymine, and uracil bases of the nucleotides can be modified with acetyl, methyl, and/or thio groups. Sequences containing nucleotide substitutions, deletions, and/or insertions can be prepared and tested using standard techniques known in the art.
As used herein, the term “percent sequence identity” or “percent identity” refers to the percentage of identical nucleotides in a linear polynucleotide sequence of a reference (“query”) polynucleotide molecule (or its complementary strand) as compared to a test (“subject”) polynucleotide molecule (or its complementary strand), or a linear polypeptide sequence of a reference polypeptide molecule as compared to a test polypeptide molecule, when the two sequences are optimally aligned (with appropriate nucleotide or amino acid insertions, deletions, or gaps totaling less than 20 percent of the reference sequence over the window of comparison). Optimal alignment of sequences for aligning a comparison window are well known to those skilled in the art and may be conducted by tools such as the local homology algorithm of Smith and Waterman, the homology alignment algorithm of Needleman and Wunsch, the search for similarity method of Pearson and Lipman, and preferably by computerized implementations of these algorithms such as GAP, BESTFIT, FASTA, and TFASTA available as part of the GCG® Wisconsin Package® (Accelrys Inc., Burlington, MA). Polynucleotides and polypeptides contemplated within the scope of the subject disclosure can also be defined in terms of identity and/or similarity ranges with those sequences of the disclosure specifically exemplified herein. In certain embodiments, the disclosure provides polypeptide sequences having at least about 70, 75, 80, 85, 90, 95, 96, 97, 98, 99, or 99.5 percent identity to a polypeptide sequences provided herein, including, but not limited to, those encoded by SEQ ID NOs:1-26. In certain embodiments, the disclosure provides polynucleotide sequences having at least about 70, 75, 80, 85, 90, 95, 96, 97, 98, 99, or 99.5 percent identity to a polynucleotide sequence provided herein, including, but not limited to, SEQ ID NOs:1-40. In addition to the nucleotide and amino acid sequences disclosed herein, homologous nucleic acid and amino acid sequences (“homologs”) from other species are also contemplated for use in certain embodiments.
In certain embodiments, the disclosure provides polynucleotides encoding polypeptides comprising the amino acid sequence provided herein, or a fragment or variant thereof. In certain embodiments, the polynucleotides encode polypeptides comprising a variant or mutant of the amino acid sequence provided herein, or combinations, fragments, or variants thereof.
Fragments and variants of a mutant polypeptide of the present disclosure can be generated as described herein and tested for the presence of enzymatic activity as described herein, or using other standard techniques known in the art. Thus, an ordinarily skilled artisan can readily prepare and test fragments and variants of a mutant polypeptide of the disclosure and determine whether the fragment or variant retains functional activity relative to full-length or a non-variant mutant polypeptide. Fragments and variants of mutant polypeptides can be tested for activity, for example using methods disclosed herein or by other methods well-known in the art.
In certain embodiments, polypeptides of the disclosure, and functional peptide fragments thereof, can be used to generate antibodies that bind specifically to a polypeptide of the disclosure, and such antibodies are contemplated within the scope of the disclosure. The antibodies of the disclosure can be polyclonal or monoclonal and can be produced and isolated using standard methods known in the art.
Polypeptide fragments according to the disclosure typically comprise a contiguous span of at least about 20, about 25, about 30, about 35, about 40 or about 45 amino acids of a sequence disclosed herein, including, but not limited to, those encoded by SEQ ID NOs:1-26. In certain embodiments, polypeptide fragments comprise about 50, about 100, about 150, about 200, about 250, about 300, about 350, about 400 or about 450 amino acids of a sequence provided herein.
Fragments of a polypeptide of the disclosure can be obtained by cleaving the polypeptides of the disclosure with a proteolytic enzyme (such as trypsin, chymotrypsin, or collagenase) or with a chemical reagent, such as cyanogen bromide (CNBr). Alternatively, peptide or polypeptide fragments can be generated in a highly acidic environment, for example at pH 2.5. Peptide or polypeptide fragments can also be prepared by chemical synthesis or using host cells transformed with an expression vector comprising a polynucleotide encoding a fragment of a polypeptide of the disclosure, for example, a mutant polypeptide that is a fragment of an amino acid sequence provided herein.
Polynucleotides useful in the present disclosure can be provided in an expression construct. Expression constructs of the disclosure generally include regulatory elements that are functional in the intended host cell in which the expression construct is to be expressed. Thus, a person of ordinary skill in the art can select regulatory elements for use in bacterial host cells, yeast host cells, plant host cells, insect host cells, mammalian host cells, and human host cells. Regulatory elements include promoters, transcription termination sequences, translation termination sequences, enhancers, and polyadenylation elements. As used herein, the term “expression construct” refers to one or a combination of nucleic acid sequences that provides for transcription of an operably linked nucleic acid sequence. As used herein, “operably linked” means two DNA molecules linked in manner so that one may affect the function of the other. Operably-linked DNA molecules may be part of a single contiguous molecule and may or may not be adjacent. For example, a promoter is operably linked with a polypeptide-encoding DNA molecule in a DNA construct where the two DNA molecules are so arranged that the promoter may affect the expression of the DNA molecule.
As used herein, the term “heterologous” refers to the relationship between two or more items derived from different sources and thus not normally associated in nature. For example, a protein-coding recombinant DNA molecule is heterologous with respect to an operably linked promoter if such a combination is not normally found in nature. In addition, a particular recombinant DNA molecule may be heterologous with respect to a cell, seed, or organism into which it is inserted when it would not naturally occur in that particular cell, seed, or organism.
The term “transgene” refers to a DNA molecule artificially incorporated into the genome of an organism as a result of human intervention, such as by plant transformation methods. As used herein, the term “transgenic” means comprising a transgene, for example a “transgenic plant” refers to a plant comprising a transgene in its genome and a “transgenic trait” refers to a characteristic or phenotype conveyed or conferred by the presence of a transgene incorporated into the plant genome. As a result of such genomic alteration, the transgenic plant is something distinctly different from the related wild-type plant and the transgenic trait is a trait not naturally found in the wild-type plant. Transgenic plants of the present disclosure comprise the recombinant DNA molecules and proteins provided herein.
An expression construct of the disclosure can comprise a promoter sequence operably linked to a polynucleotide sequence encoding a modified polypeptide of the disclosure. Promoters can be incorporated into a polynucleotide using standard techniques known in the art. Multiple copies of promoters or multiple promoters can be used in an expression construct of the disclosure. In a preferred embodiment, a promoter can be positioned about the same distance from the transcription start site in the expression construct as it is from the transcription start site in its natural genetic environment. Some variation in this distance is permitted without substantial decrease in promoter activity. A transcription start site is typically included in the expression construct.
Embodiments of the disclosure further provide a recombinant DNA molecule encoding a polypeptide, wherein the recombinant DNA molecule is further defined as operably linked to a heterologous regulatory element. In specific embodiments, the heterologous regulatory element is a promoter functional in a plant cell. In further embodiments, the promoter is an inducible or root specific promoter.
If the expression construct is to be provided in or introduced into a plant cell, then plant viral promoters, such as, for example, a cauliflower mosaic virus (CaMV) 35S (including the enhanced CaMV 35S promoter (see, e.g., U.S. Pat. No. 5,106,739)), a CaMV 19S promoter or a cassava vein mosaic virus promoter can be used. Other promoters that can be used for expression constructs in plants include, but are not limited to, zein promoters including maize zein promoters, prolifera promoter, Ap3 promoter, heat shock promoters, T-DNA 1′- or 2′-promoter of A. tumefaciens, polygalacturonase promoter, chalcone synthase A (CHS-A) promoter from petunia, tobacco PR-1a promoter, ubiquitin promoter, actin promoter, alcA gene promoter, pin2 promoter (Xu, et al., Plant Mol. Biol. 22:573-588, 1993), maize WipI promoter, maize trpA gene promoter (U.S. Pat. No. 5,625,136), maize CDPK gene promoter, and RUBISCO SSU promoter (U.S. Pat. No. 5,034,322) can also be used. Constitutive promoters (such as the CaMV, ubiquitin, actin, or NOS promoter), developmentally-regulated promoters, and inducible promoters (such as those promoters than can be induced by heat, light, hormones, or chemicals) are also contemplated for use with polynucleotide expression constructs of the disclosure.
Expression constructs of the disclosure may optionally contain a transcription termination sequence, a translation termination sequence, a sequence encoding a signal peptide, and/or enhancer elements. Transcription termination regions can typically be obtained from the 3′ untranslated region of a eukaryotic or viral gene sequence. Transcription termination sequences can be positioned downstream of a coding sequence to provide for efficient termination. A signal peptide sequence is a short amino acid sequence typically present at the amino terminus of a protein that is responsible for the relocation of an operably linked mature polypeptide to a wide range of post-translational cellular destinations, ranging from a specific organelle compartment to sites of protein action and the extracellular environment. Targeting gene products to an intended cellular and/or extracellular destination through the use of an operably linked signal peptide sequence is contemplated for use with the polypeptides of the disclosure. Classical enhancers are cis-acting elements that increase gene transcription and can also be included in the expression construct. Classical enhancer elements are known in the art, and include, but are not limited to, the CaMV 35S enhancer element, cytomegalovirus (CMV) early promoter enhancer element, and the SV40 enhancer element. Intron-mediated enhancer elements that enhance gene expression are also known in the art. These elements should be present within the transcribed region and are orientation dependent. Examples include the maize shrunken-1 enhancer element (Clancy and Hannah, Plant Physiol. 130:918-929, 2002). Expression constructs may optionally contain a 5′-untranslated region (5′-UTR), as described in further detail below.
One aspect of the disclosure includes plant cells, plant tissues, plants, and seeds that comprise the recombinant DNA provided by the disclosure. Suitable methods for transformation of host plant cells for use with the current disclosure include virtually any method by which DNA can be introduced into a cell (for example, where a recombinant DNA construct is stably integrated into a plant chromosome) and are well-known in the art. For example, by direct delivery of DNA such as by PEG-mediated transformation of protoplasts, by desiccation/inhibition-mediated DNA uptake, by electroporation (U.S. Pat. No. 5,384,253, specifically incorporated herein by reference in its entirety), or by agitation with silicon carbide fibers (U.S. Pat. Nos. 5,302,523 and 5,464,765, both specifically incorporated herein by reference in its entirety).
Two effective methods for cell transformation are Agrobacterium-mediated transformation and microprojectile bombardment-mediated transformation. Microprojectile bombardment methods are illustrated, for example, in U.S. Pat. Nos. 5,550,318, 5,538,880, 6,160,208, and 6,399,861. Agrobacterium-mediated transformation methods are described, for example in U.S. Pat. No. 5,591,616. Transformation of plant material is practiced in tissue culture on nutrient media, for example a mixture of nutrients that allow cells to grow in vitro. Recipient cell targets include, but are not limited to, meristem cells, shoot tips, hypocotyls, calli, immature or mature embryos, and gametic cells such as microspores and pollen. Callus can be initiated from tissue sources including, but not limited to, immature or mature embryos, hypocotyls, seedling apical meristems, microspores and the like. Cells containing a transgenic nucleus are grown into transgenic plants.
In transformation, DNA is typically introduced into only a small percentage of target plant cells in any one transformation experiment. Marker genes are typically used to provide an efficient system for identification of those cells that are stably transformed by receiving and integrating a recombinant DNA molecule into their genomes. Preferred marker genes provide selective markers which confer resistance to a selective agent, such as an antibiotic or an herbicide. Any of the herbicides to which plants of this disclosure can be resistant is an agent for selective markers. Potentially transformed cells are exposed to the selective agent. In the population of surviving cells are those cells where, generally, the resistance-conferring gene is integrated and expressed at sufficient levels to permit cell survival. Cells can be tested further to confirm stable integration of the exogenous DNA. Commonly used selective marker genes include those conferring resistance to antibiotics such as kanamycin and paromomycin (nptII), hygromycin B (aph IV), spectinomycin (aadA) and gentamycin (aac3 and aacC4) or resistance to herbicides such as glufosinate (bar or pat), dicamba (DMO) and glyphosate (aroA or EPSPS). Examples of such selectable markers are illustrated in U.S. Pat. Nos. 5,550,318, 5,633,435, 5,780,708 and 6,118,047. Markers that provide an ability to visually screen transformants can also be employed, for example, a gene expressing a colored or fluorescent protein such as a luciferase or green fluorescent protein (GFP) or a gene expressing a beta-glucuronidase or uidA gene (GUS) for which various chromogenic substrates are known.
The present disclosure provides methods and constructs for regenerating a plant from a cell with modified genomic DNA resulting from genome editing. The regenerated plant can then be used to propagate additional plants. The disclosure thus provides plants produced by the methods disclosed herein. Plants of the present disclosure may be monocots or dicots, and may include, for example, rice, wheat, barley, oats, rye, sorghum, maize, soybean, alfalfa, sunflower, cotton, canola, sugar beet, sweet potato, tomato, strawberry, tobacco, banana, grape, curcubits and pepper plants, and may also include coastal woody shrub and vine species, such as beach plum, wax myrtle, mesquite, salt cedar, crossvine, with vine, acacia and laurel.
In addition to direct transformation of a particular plant genotype with a construct prepared according to the current disclosure, transgenic plants may be made by crossing a plant having a selected DNA of the disclosure to a second plant lacking the construct. For example, a selected coding sequence can be introduced into a particular plant variety by crossing, without the need for ever directly transforming a plant of that given variety. Therefore, the current disclosure not only encompasses a plant directly transformed or regenerated from cells which have been transformed in accordance with the current disclosure, but also the progeny of such plants. As used herein, the term “progeny” denotes the offspring of any generation of a parent plant prepared in accordance with the instant disclosure, wherein the progeny comprises a selected DNA construct prepared in accordance with the disclosure. “Crossing” a plant to provide a plant line having one or more added transgenes relative to a starting plant line, as disclosed herein, is defined as the techniques that result in a transgene of the disclosure being introduced into a plant line by crossing a plant of a starting line with a plant of a donor plant line that comprises a transgene of the disclosure. To achieve this one could, for example, perform the following steps: (a) plant seeds of the first (starting line) and second (donor plant line that comprises a transgene of the disclosure) parent plants; (b) grow the seeds of the first and second parent plants into plants that bear flowers; (c) pollinate a flower from the first parent plant with pollen from the second parent plant; and (d) harvest seeds produced on the parent plant bearing the fertilized flower. Backcrossing is herein defined as the process including the steps of: (a) crossing a plant of a first genotype containing a desired gene, DNA sequence or element to a plant of a second genotype lacking the desired gene, DNA sequence or element; (b) selecting one or more progeny plant containing the desired gene, DNA sequence or element; (c) crossing the progeny plant to a plant of the second genotype; and (d) repeating steps (b) and (c) for the purpose of transferring a desired DNA sequence from a plant of a first genotype to a plant of a second genotype.
Introgression of a DNA element into a plant genotype is defined as the result of the process of backcross conversion. A plant genotype into which a DNA sequence has been introgressed may be referred to as a backcross converted genotype, line, inbred, or hybrid. Similarly, a plant genotype lacking the desired DNA sequence may be referred to as an unconverted genotype, line, inbred, or hybrid.
Targeted modification of plant genomes through the use of genome editing methods can be used to create improved mutant or transgenic plant lines through modification or insertion of plant genomic DNA. In addition, genome editing methods can enable targeted insertion of multiple nucleic acids of interest (a trait stack) into a plant genome. As used herein “site-directed integration” refers to genome editing methods the enable targeted insertion of one or more nucleic acids of interest into a plant genome. Suitable methods for altering a wild-type DNA sequence or a preexisting transgenic sequence or for inserting DNA into a plant genome at a pre-determined chromosomal site include any method known in the art. Exemplary methods include the use of sequence specific nucleases, such as zinc-finger nucleases, engineered or native meganucleases, TALE-endonucleases, or an RNA-guided endonucleases (for example, a Clustered Regularly Interspersed Short Palindromic Repeat (CRISPR)/Cas9 system, a CRISPR/Cpf1 system, a CRISPR/CasX system, a CRISPR/CasY system, a CRISPR/Cascade system). Several embodiments relate to methods of genome editing by using single-stranded oligonucleotides to introduce precise base pair modifications in a plant genome, as described by Sauer et al., Plant Physiology 170(4):1917-1928 (2016). Methods of genome editing to modify, delete, or insert nucleic acid sequences into genomic DNA are known in the art. In the present disclosure, such methodology can be used to redirect expression of the MYB36 and MYB41 genes by altering the promoter sequences. Likewise, the coding sequences of the PIPs and TIPs can be modified, and the promoters altered for root expression as defined herein. In a similar fashion, the expression of the osmoticum biosynthesis and transporter genes can be redirected to xylem parenchyma by modification of the promoter sequences.
Several embodiments may therefore relate to a recombinant DNA construct comprising an expression cassette(s) encoding a site-specific nuclease and, optionally, any associated protein(s) to carry out genome modification. These nuclease-expressing cassette(s) may be present in the same molecule or vector as a donor template for templated editing or an expression cassette comprising nucleic acid sequence encoding a protein as described herein (in cis) or on a separate molecule or vector (in trans). Several methods for site-directed integration are known in the art involving different sequence-specific nucleases (or complexes of proteins or guide RNA or both) that cut the genomic DNA to produce a double strand break (DSB) or nick at a desired genomic site or locus. As understood in the art, during the process of repairing the DSB or nick introduced by the nuclease enzyme, the donor template DNA, transgene, or expression cassette may become integrated into the genome at the site of the DSB or nick. The presence of the homology arm(s) in the DNA to be integrated may promote the adoption and targeting of the insertion sequence into the plant genome during the repair process through homologous recombination, although an insertion event may occur through non-homologous end joining (NHEJ). As used herein, the term “double-strand break inducing agent” refers to any agent that can induce a double-strand break (DSB) in a DNA molecule. In some embodiments, the double-strand break inducing agent is a site-specific genome modification enzyme.
As used herein, the term “site-specific genome modification enzyme” refers to any enzyme that can modify a nucleotide sequence in a sequence-specific manner. In some embodiments, a site-specific genome modification enzyme modifies the genome by inducing a single-strand break. In some embodiments, a site-specific genome modification enzyme modifies the genome by inducing a double-strand break. In some embodiments, a site-specific genome modification enzyme comprises a cytidine deaminase. In some embodiments, a site-specific genome modification enzyme comprises an adenine deaminase. In the present disclosure, site-specific genome modification enzymes include endonucleases, recombinases, transposases, deaminases, helicases and any combination thereof. In some embodiments, the site-specific genome modification enzyme is a sequence-specific nuclease.
In one aspect, the endonuclease is selected from a meganuclease, a zinc-finger nuclease (ZFN), a transcription activator-like effector nucleases (TALEN), an Argonaute (non-limiting examples of Argonaute proteins include Thermus thermophilus Argonaute (TtAgo), Pyrococcus furiosus Argonaute (PfAgo), Natronobacterium gregoryi Argonaute (NgAgo), an RNA-guided nuclease, such as a CRISPR associated nuclease (non-limiting examples of CRISPR associated nucleases include Cas1, Cas1B, Cas2, Cas3, Cas4, Cas5, Cas6, Cas7, Cas8, Cas9 (also known as Csn1 and Csx12), Cas10, Csy1, Csy2, Csy3, Cse1, Cse2, Csc1, Csc2, Csa5, Csn2, Csm2, Csm3, Csm4, Csm5, Csm6, Cmr1, Cmr3, Cmr4, Cmr5, Cmr6, Csb1, Csb2, Csb3, Csx17, Csx14, Csx10, Csx16, CsaX, Csx3, Csx1, Csx15, Csf1, Csf2, Csf3, Csf4, Cpf1, CasX, CasY, homologs thereof, or modified versions thereof).
In some embodiments, the site-specific genome modification enzyme is a recombinase. Non-limiting examples of recombinases include a tyrosine recombinase attached to a DNA recognition motif provided herein is selected from the group consisting of a Cre recombinase, a Gin recombinase, a Flp recombinase, and a Tnp1 recombinase. In an aspect, a Cre recombinase or a Gin recombinase provided herein is tethered to a zinc-finger DNA-binding domain, or a TALE DNA-binding domain, or a Cas9 nuclease. In another aspect, a serine recombinase attached to a DNA recognition motif provided herein is selected from the group consisting of a PhiC31 integrase, an R4 integrase, and a TP-901 integrase. In another aspect, a DNA transposase attached to a DNA binding domain provided herein is selected from the group consisting of a TALE-piggyBac and TALE-Mutator.
Any DNA of interest provided herein can be integrated into a target site of a chromosome sequence by introducing the DNA of interest and the provided site-specific genome modification enzymes. Any method provided herein can utilize any site-specific genome modification enzyme provided herein.
The inventors separately designed, assembled and tested three complex components needed to encode a synthetic desalination circuit in plants. First, studies were performed to prove that each of these components was functional. After the three components were shown to be functional, they were assembled to produce a complete desalination gene circuit. Plants containing the complete desalination gene circuit survive in salt water with salinity levels greater than that of the ocean (600 mM NaCl) and secrete (via an engineered guttation) water with ionic composition comparable to that of bottled water.
Component #1: Genetically Encoded Physical or Structural (Moon, et al., Austr. J. Plant Physiol. 13:637-648, 1986) Barriers. Early work on how mangroves desalinate seawater suggested that a non-metabolic “ultra-filter” is involved (Scholander, 1968, supra). The presently described embodiment of the synthetic desalination gene circuit targets the biosynthesis of two biological structures to the epidermal cells of plant roots, where they form a physical barrier and ultra-filter for the penetration of salt. While the present example describes targeting expression to epidermal cells, those of skill in the art will recognize that expression can be targeted to any cell type toward the exterior of the root, including those that could be recognized as exodermis, periderm (such as the phellem (cork), phellogen (cork cambium) and phelloderm), rhytidome, or some types of bark. Regulatory genes direct production of two non-metabolic components: suberin, a water proofing and filtering component, and the Casparian Strip, a component forming a three-dimensional matrix that effectively plugs gaps between cells, somewhat analogous to tight junctions in mammalian cells (Geldner, Ann. Rev. Plant Biol. 64:531-558, 2013).
Root epidermal targeting components were developed by analysis and production of root epidermal promoters. While the bioinformatics and other literature (Moreno-Risueno, et al., Science 350:426-430, 2015) describes the existence of transcriptional promoters as “root epidermal specific,” in planta analysis of nine natural promoters in plant roots showed that this characterization was not always accurate (Table 2).
It was found that three root transcriptional promoters (ABCtrans (SEQ ID NO:27). CLE14 and IRT2) have strong preference for the root epidermis in some transgenic lines. In addition, two variants (4-block and 7-block; Table 3) of an initial synthetic promoter for the root epidermis (SynEpiProm Ver. 1.0) and an improved root synthetic epidermal promoter (SynEpiProm Ver. 2.0) were designed, assembled and tested. The 4-block (SEQ ID NO:32) and 7-block (SEQ ID NO:33) synthetic promoters express primarily in the root epidermis and xylem. Based on this analysis, the ABC transporter root epidermal promoter (SEQ ID NO:27) was initially chosen to direct expression of the synthetic suberin component and the synthetic Casparian Strip to the root epidermis.
The Casparian Strip produces a three-dimensional matrix containing lignin, a plastic-like molecule that functions much like tight junctions in mammalian cells, effectively forming an impermeable barrier to fluid (i.e., plugging any gaps between cells) (Geldner, Curr. Biol. 23:R1025-1026, 2013). Expression of the Casparian Strip is controlled by the MYB36 transcription factor (Kamiya, et al., Proc. Natl. Acad. Sci. USA 112:10533-10538, 2015). The Casparian Strip is normally found in a specialized cell group in plant roots, the endodermis, a cylindrical-like group of cells that surrounds the vascular system. To direct formation of this three-dimensional matrix to the epidermis, the ABC transporter promoter was used in the presence or absence of a translational enhancer, the 5′-leader sequence (omega) of tobacco mosaic virus (TMV).
Root cross-sections from T1 plant TKK649-8-14, expressing the MYB36 gene (SEQ ID NO:10) under control of the epidermal ABC transporter promoter (SEQ ID NO:27), and the omega enhancer to enhance translation, were stained with berberine hemisulfate (a lignin stain) and aniline blue (to quench autofluorescence from root cells) (
Results showed that the ABC transporter promoter with the translational enhancer effectively directed expression of a synthetic Casparian Strip to the root epidermis. It is notable that some plant species with salt tolerance have a natural duplication of the Casparian Strip in the epidermis and epidermal-like cells (periderm) (Meyer, et al., J. Exp. Bot. 62:1911-1926, 2011).
Suberin is a lipid-phenolic biopolyester forming a protective barrier in the root endodermis and other parts of the plant. In brief, suberin is a type of somewhat water-proofing material made of complex hydrophobic molecules secreted by the plant outside the plasma membrane and inside the plant cell wall. Suberin varies between different plant stages, plant tissues and plant species (Vishwanath, et al., Plant Cell. Rep. 34:573-586, 2015). Suberin forms a series of layers or lamellae that function to inhibit entry of sodium chloride and other ions. Nature has been one of the best engineers in doing this, as water molecules, with a radius of 137 picometers (pm) (Zhang and Xu, Am. Mineral. 80:670-675, 1995), can move through the layers of suberin, while sodium ions solvated with water have a molecular radius of approximately 358 pm and are unable to move through the layers of suberin (Volkov, et al., Bioelectrochem. Bioenerg. 42:153-160, 1997). The synthetic suberin blocks movement of NaCl, but allows movement of molecules such as water. Expression of suberin can be controlled by expression of the MYB41 gene. Ectopic expression of the MYB41 genes in leaves induced production of suberin-like lamellae with a striking resemblance to lamellae normally found in the cell walls of suberized peridermal and endodermal cells from mature and young roots, respectively (Kosma, et al., Plant J. 80:216-229, 2014). However, the MYB41 promoter is not normally expressed in root epidermal cells (Brady, et al., Science 318:801-806, 2007); in addition, ectopic expression of the MYB41 gene in roots did not lead to enhanced production of suberin, with suberin only found in its natural location, in the endodermis.
Initially, MYB41 was the only factor shown to control the synthesis and deposition of suberin. Subsequently, there have been reports of other Arabidopsis MYB transcription factors besides MYB41 activating suberin biosynthesis. MYB107 and MYB9 homologs were identified as regulators of suberin in angiosperms (Lashbrooke, et al., Plant Cell 28:2097-2116, 2016) and MYB107 has been shown to control biosynthesis of suberin in the seed coat (Gou, et al., Plant Physiol. 173:1045-1058, 2017). A clade of MYB factors potentially involved in suberin formation has been identified that contains 15 Arabidopsis MYBs, including MYB41 (Lashbrooke, et al., 2016, supra). It is likely there is functional redundancy within this clade of Arabidopsis MYB factors, allowing spatial/temporal control of suberin biosynthesis by different MYB factors, induced by various developmental or environmental signals. As such, although the present example describes the use of MYB41, any of these other MYB factors are also contemplated for use in the present disclosure.
The MYB41 protein is known to be activated by phosphorylation through the mitogen activated protein kinase (MAPK) signaling pathway, a complex pathway involved in plant development and stress response (My, et al., Biochem. Biophys. Res. Commun. 422:181-186, 2012).
Two potential reasons were investigated as to why expressing MYB41 in root tissues (other than the endodermis) does not result in enhanced suberin synthesis. First, it is possible the root tissues other than the endodermis do not express the specific MAPKs that phosphorylate and activate MYB41. Second, it is possible that the perception of the stress hormone abscisic acid (ABA) and/or environmental stress is not strong enough in the root epidermis to activate MYB41. This was investigated in transgenic Arabidopsis roots containing the construct TKK644-1, a T-DNA with the ABC transporter promoter (SEQ ID NO:27) driving expression of the MYB41 gene. Transgenic roots were exposed to 10 mM ABA. The results provided evidence that suberin is not produced in response to the stress hormone ABA in Arabidopsis roots. Because the Arabidopsis roots were completely submerged in ABA, these data show that the MAPK responsible for phosphorylating and activating MYB41 is not active in the root epidermis.
The MYB41 protein is phosphorylated by MAPKs on serine 251. In some proteins mutating a serine residue to an aspartate residue mimics the structure of phospho-serine because of the structural similarity. To demonstrate that this would work for MYB41 in roots, a MYB41 gene was engineered to encode a MYB protein with an aspartate at residue 251 (MYB41 phospho-mimic; SEQ ID NO:13), which was then expressed in transgenic Arabidopsis plants under control of an ABC transporter promoter (SEQ ID NO:27). A root cross-section of an Arabidopsis plant transformed with the MYB41 phospho-mimic (plant line KJM325-3) under control of the ABC transporter epidermal promoter stained with fluorol yellow, which stains suberin, showed that both the naturally occurring endodermal suberin and the engineered epidermal suberin were visible (
Collectively, these three accomplishments allowed targeted expression of suberin and a synthetic Casparian Strip to the cells at the exterior of the root, the root epidermis. The synthetic Casparian Strip forms a water-tight junction that prevents salt water from penetrating between the root epidermal cells that contact the environment. Suberin forms a Na+ filtering and partial water-proofing barrier in root epidermal cells. Hence, the first component is designed to filter salt, reduce detrimental effects of salt water exposure, and prevent water, salt water, or seawater or otherwise contaminated water from entering a plant between root epidermal cells. Thus, the suberin expressed in the root epidermis and the Casparian Strip “plugging” gaps between cells likely constitute the non-metabolic ultra-filter previously proposed (Scholander, 1968, supra).
Component #2: Genetically Encoded Water Transporting and Salt Collection System. While a non-metabolic filter was originally proposed to filter or desalinate seawater, later reports suggested the plant's membrane system (symplast) also plays a role in this process (Moon, et al., 1986, supra). To produce a synthetic water transport/salt collection system in plants, the present disclosure uses aquaporins, specialized proteins that transport water and sequester salt ions in vacuoles. Aquaporin genes from mangroves, were genetically encoded and expression was directed to cells in the root. Mangroves must be efficient at this process to survive continual flooding by the ocean and the hypersaline environments that build up in coastal areas, hence, genetic information available for mangrove aquaporins was used. Because complete genome information for any species of mangroves is still lacking, incomplete information for mangrove aquaporins was filled-in with genetic information for aquaporins from halophytes (salt loving plants; e.g., when lacking complete information from mangroves, halophyte sequences were used to complete the 5′ codon region). In developing the synthetic desalination circuit, a variety of aquaporin genes were first assembled and tested in planta.
Then expression of two types of synthetic mangrove aquaporins was directed in cells throughout the root using a promoter (KC1) that was confirmed to be properly expressed throughout root cells. This provided a continuous symplastic pathway for water to move radially from the outer portion of the root to the vasculature, as well as increase the presence of salt-sequestering mangrove aquaporins, to target any NaCl that might enter the root, to the vacuole for safe exclusion of the salt.
Component 2A is reprogrammed mangrove aquaporins, specifically, PIPs (plasma membrane intrinsic proteins), that enable the desalination plants to transport water (not seawater) through the symplastic system of root cells. Data suggests that two PIPs are needed for correct function. Mangrove aquaporins were engineered and tested with drought and salt stress assays. The PIPs with the most promising function were AoPIP 1.2, derived from the mangrove species Avicennia officinalis, and BgPIP2, derived from the mangrove species Bruguiera gymnorrhiza. These mangrove aquaporins were targeted to the plasma membrane. Below, results are presented first for PIPs (drought and salt tolerance assays to verify function) and then for TIPs (tonoplast intrinsic membrane proteins), which is Component 2B (drought and salt tolerance assays to verify function).
Drought stress tolerance was studied in a transgenic Arabidopsis line where the mangrove aquaporin AoPIP1.2 (SEQ ID NO:1) was expressed in the epidermis using the ABC transporter promoter (SEQ ID NO:27). Plant line TKK630 (pABCtrans_AoPIP1.2) and wild-type plants were either watered regularly for 10 days or not watered (drought treatment) for 10 days. Some but not all drought-treated transgenic plants were more viable than the wild-type. The same drought-stressed plants were watered after the end of the 10 day drought treatment. Five of the seven transgenic lines recovered, while none of the wild-type plants recovered.
Drought stress tolerance was also studied in a transgenic Arabidopsis line where mangrove aquaporin AoPIP1.2 (SEQ ID NO:1) was expressed in the endodermis. Plant line TKK589 (pSCR_AoPIP1.2) and wild-type plants were either watered regularly for 11 days or not watered for 11 days (drought stress treatment). The transgenic plants tested under drought conditions remained viable after 11 days of no water. The drought-stressed transgenic lines were then watered after the end of the drought treatment; all of the transgenic lines recovered.
Drought stress tolerance was additionally studied in Arabidopsis plants expressing the mangrove aquaporin gene BgPIP2 (SEQ ID NO:3) using the ABC transporter promoter (SEQ ID NO:27). Plants from line TKK632 (ABCtrans_BgPIP2, an epidermal promoter driving a mangrove aquaporin) or wild-type plants were either watered regularly for 10 days or not watered for 10 days. After 10 days without water, the wild-type plants showed severe drought stress, while the TKK632 plants were still viable. This showed that the TKK632 plants were more tolerant to drought than the wild-type plants.
Table 4 summarizes the results of the drought tolerance assays in Arabidopsis plants with PIP genes.
Table 5 summarizes the results of the salt tolerance assays in Arabidopsis plants with PIP genes.
Component 2B is additional aquaporins, specifically, TIPs (Tonoplast intrinsic membrane proteins). While it was fully anticipated that mangrove TIPs would function, genomic information was lacking for these, and also the TIPs from Kandelia candel and Bruguiera gymnorrhiza did not show tissue specific expression with a C-terminal GFP fusion. Thus, characterized TIPs from a halophytic species, Eutrema salsuginea (salt cress) were used. As with the PIPs, the separate TIPs components were first assembled and tested for function in planta. The most promising TIPs were TsTIP 1.1 (SEQ ID NO:9) and TsTIP 1.2 (SEQ ID NO:6), both derived from Eutrema salsugineum (salt cress). Of these two, TsTIP1.2 resulted in more tolerant plants during salt and drought stress assays (see below).
Drought stress experiments were performed to test drought tolerance in Arabidopsis plants expressing a salt cress aquaporin gene. Plants from line TKK668 (pABCtrans_Ts TIP1.1, an epidermal promoter driving a salt cress aquaporin), line TKK669 (pABCtrans_TsTIP1.2, an epidermal promoter driving a salt cress aquaporin), and wild-type Arabidopsis controls were either watered daily for 10 days or not watered for 10 days. Then the drought-stressed plants were watered once at the end of 10 days and allowed to recover for one day. Most drought-stressed transgenic plants recovered viability after re-watering, in contrast to the wild-type plants, which were unable to recover.
Table 6 summarizes the results of the drought tolerance assays in Arabidopsis plants with TIP genes.
Studies were performed to test salt tolerance in transgenic Arabidopsis plants expressing a salt cress aquaporin gene. Plants from line TKK669 (pABCtrans_TsTIP1.2, an epidermal promoter driving a salt cress aquaporin) and wild-type Arabidopsis controls were either watered daily with tap water for 12 days or watered with 350 mM NaCl for 12 days. All but one salt-stressed transgenic plant, and no wild-type plants, showed continued growth in the presence of salt and 16 plants bolted, with seven plants setting seed.
Table 7 summarizes the results of the salt tolerance assays in Arabidopsis plants with TIP genes. Aquaporins AoPIP1.2, BgPIP2, and TsTIP1.2 were selected for use with the complete desalination circuit in the present Example.
Component #3: Retain Pure Water and Pump Water to Leaves for Collection. Because plants filtering water would still be surrounded by the salt water (or otherwise contaminated water), simple osmosis could drive the purified water out of the roots. To overcome this, a mechanism was engineered to allow the desalination plants to retain and pump (secrete) the purified water. A type of water secretion by plants known as guttation was used.
Mangroves maintain a high osmotic potential within their vascular tissue, which is thought to prevent the sea from recovering the filtered water by simple osmosis and allows water to be transported to the shoot and leaves. The presently described synthetic osmotic gradient in the vascular tissue involves two steps: first, targeting mannitol biosynthesis genes to vascular tissue cells capable of biosynthesizing a sugar (xylem parenchyma cells); and second, targeting a mannitol transporter to the apoplast of the xylem parenchyma cells. Because the xylem parenchyma apoplast is contiguous with the apoplast of the water transport cells (vessel elements, tracheary elements), mannitol synthesized in the xylem parenchyma will be transported to the xylem elements. The higher amount of mannitol in the vasculature drives the flow of water into the vasculature.
As before, expression of the transcriptional promoters was checked and verified to direct expression of the components. Multiple putative xylem and xylem parenchyma specific promoters were checked (Table 8), and initial efforts were focused on the XCP1 (SEQ ID NO:31) and CESA7 (SEQ ID NO:29) promoters.
Component 3A is a mannitol biosynthesis gene (mannose-6-phosphate-reductase, M6PR; SEQ ID NO:19) under control of a xylem parenchyma-specific promoter (XCP1), which directs production of this specialized sugar to the xylem parenchyma. This gene causes the localized over-production of sugar in a cytoplasmic cell in the vascular tissue (xylem parenchyma), sometimes called vessel associated cells (VACs).
Component 3B is a mannitol transporter gene (MTR; SEQ ID NO:16) under control of the xylem parenchyma specific CESA7 promoter. Expression of this gene is also targeted to the xylem parenchyma or VACs, but in such a way that it will pump mannitol to the apoplast (cell wall). Because the xylem parenchyma's apoplast is contiguous with the xylem's apoplast, mannitol will enter the xylem (dead cells). When plants pump an osmoticum such as mannitol into the apoplast, water follows to substantially increase osmotic pressure of the xylem. This prevents water purified by the plant from diffusing back out of the plant by osmosis.
Once components 1, 2 and 3 described above were assembled, tested and functionally verified, all three components were assembled into a complete desalination genetic circuit. One version was assembled in which the complete circuit was contained in two plasmids for plant transformation (
Table 9 shows analysis of water samples and plant-secreted water obtained from plants that were watered with tap water or 600 mM NaCl. When the water source for watering the plants was tap water, both control and transgenic plant secreted (guttated) water of high purity. In contrast, when the water source for watering the plants was 600 mM NaCl, control plants did not secrete any water, whereas the synthetic desalination plants secreted water with a salinity content comparable to that of bottled water. The control plants also showed the appearance of a purple-red color, indicating the control plants were highly stressed. The control plants typically died soon after salt water treatment.
Collectively these data provide definitive evidence that plants genetically modified with the presently described synthetic desalination circuit can filter salt water and secrete (guttate) pure water. This photosynthetically powered desalination system can be used to purify salt water, seawater and also various types of contaminated water. This phytodesalination process provides a pathway toward sustainable human life on earth, and provides a means to grow crops and other plants under saline conditions.
The term “about” is used herein to indicate that a value includes the standard deviation of error for the device or method being employed to determine the value. The use of the term “or” in the claims is used to mean “and/or” unless explicitly indicated to refer to alternatives only or the alternatives are mutually exclusive, although the disclosure supports a definition that refers to only alternatives and to “and/or.” When not used in conjunction closed wording in the claims or specifically noted otherwise, the words “a” and “an” denote “one or more.”
The terms “comprise,” “have,” and “include” are open-ended linking verbs. Any forms or tenses of one or more of these verbs, such as “comprises,” “comprising,” “has,” “having,” “includes,” and “including,” are also open-ended. For example, any method that “comprises,” “has” or “includes” one or more steps is not limited to possessing only those one or more steps and also covers other unlisted steps. Similarly, any cell that “comprises,” “has” or “includes” one or more traits is not limited to possessing only those one or more traits and covers other unlisted traits.
While the disclosure has been described in connection with specific embodiments thereof, it will be understood that the present disclosure is capable of further modifications by one of skill in the art. It is to be understood that, unless otherwise indicated, the present disclosure is not limited to particular materials, reagents, reaction materials, manufacturing processes, or the like, as such can vary. It is also to be understood that the terminology used herein is for purposes of describing particular embodiments only, and is not intended to be limiting. It is also possible in the present disclosure that steps can be executed in different sequence where this is logically possible. The present disclosure is therefore intended to encompass any variations, uses, or adaptations of the invention following, in general, the principles of the invention and including such departures from the present disclosure as come within known or customary practice within the art to which the invention pertains and as may be applied to the essential features herein before set forth.
All of the compositions and/or methods disclosed and claimed herein can be made and executed without undue experimentation in light of the present disclosure. While the compositions and methods of this disclosure have been described in terms of preferred embodiments, it will be apparent to those of skill in the art that variations may be applied to the compositions and/or methods and in the steps or in the sequence of steps of the method described herein without departing from the concept, spirit and scope of the invention. More specifically, it will be apparent that certain agents that are both chemically and physiologically related may be substituted for the agents described herein while the same or similar results would be achieved. All such similar substitutes and modifications apparent to those skilled in the art are deemed to be within the spirit, scope and concept of the invention as defined by the appended claims.
All publications, patents, patent publications, and nucleic acid and amino acid sequences cited are incorporated by reference herein in their entirety for all purposes.
This application is a continuation application of co-pending U.S. patent application Ser. No. 16/492,584, filed Sep. 9, 2019, which is a 371 National Stage application of International Application No. PCT/US2018/024053, filed Mar. 23, 2018, which claims the priority of U.S. Provisional Appl. Ser. No. 62/475,642, filed Mar. 23, 2017, the entire disclosures of which are incorporated herein by reference in their entirety.
This invention was made with government support under grant HR0011-16-2-0005 awarded by the Department of Defense/Defense Advanced Research Projects Agency. The government has certain rights in the invention.
| Number | Date | Country | |
|---|---|---|---|
| 62475642 | Mar 2017 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 16492584 | Sep 2019 | US |
| Child | 18320582 | US |
